Compounds > clonazepam

clonazepam and ziprasidone

clonazepam has been researched along with ziprasidone in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	9 (75.00)	29.6817
2010's	3 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andricopulo, AD; Moda, TL; Montanari, CA	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Coffey, B	1
Bares, M; Kopecek, M; Mohr, P	1
Jebaraj, P; Rajkumar, AP; Tharyan, P	1
Varma, A; Wickham, R	1
Camargos, ST; Cardoso, FE; Prais, HA; Viana, Bde M	1
Altun, NS; Budak, F; Dündar, S; Kutlu, A	1

Reviews

1 review(s) available for clonazepam and ziprasidone

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

11 other study(ies) available for clonazepam and ziprasidone

Article	Year
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Clinical case presentation: therapeutic challenges in adolescent-onset bipolar disorder. Journal of child and adolescent psychopharmacology, 2003,Winter, Volume: 13, Issue:4 Topics: Adolescent; Aggression; Anti-Anxiety Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Clonazepam; Diagnosis, Differential; Education; Family; GABA Modulators; Haloperidol; Hospitalization; Humans; Irritable Mood; Lithium; Lorazepam; Male; Piperazines; Psychiatric Status Rating Scales; Sexual Behavior; Thiazoles; Valproic Acid	2003
Ziprasidone-induced galactorrhea: a case report. Neuro endocrinology letters, 2005, Volume: 26, Issue:1 Topics: Adult; Anticonvulsants; Antipsychotic Agents; Clonazepam; Depressive Disorder, Major; Female; Galactorrhea; Humans; Lithium; Piperazines; Prolactin; Recurrence; Thiazoles	2005
Multi-drug overdose risperidone, ziprasidone, valproate, trihexyphenidyl, and clonazepam. The Journal of the Association of Physicians of India, 2007, Volume: 55 Topics: Adult; Antipsychotic Agents; Clonazepam; Drug Overdose; Drug Prescriptions; Female; Humans; Piperazines; Polypharmacy; Risperidone; Schizophrenia, Paranoid; Thiazoles; Trihexyphenidyl; Valproic Acid	2007
Ziprasidone-associated mania in a case of obssessive-compulsive disorder. CNS spectrums, 2007, Volume: 12, Issue:8 Topics: Anticonvulsants; Bipolar Disorder; Citalopram; Clonazepam; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Thiazoles	2007
Ziprasidone-related oculogyric crisis in an adult. Clinical neurology and neurosurgery, 2009, Volume: 111, Issue:10 Topics: Adult; Antipsychotic Agents; Clonazepam; Dyskinesia, Drug-Induced; Electroencephalography; Female; GABA Modulators; Humans; Ocular Motility Disorders; Oculomotor Muscles; Piperazines; Schizophrenia; Thiazoles	2009
Ziprasidone induced tardive cervical dystonia. Psychopharmacology bulletin, 2009, Volume: 42, Issue:4 Topics: Antipsychotic Agents; Botulinum Toxins, Type A; Clonazepam; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Neuromuscular Agents; Piperazines; Thiazoles	2009